US Patent 10028923 Biguanide compositions and methods of treating metabolic disorders
Patent 10028923 was granted and assigned to Elcelyx Therapeutics Inc. on July, 2018 by the United States Patent and Trademark Office.
Something went wrong.
Try refreshing the page.
Find more entities like US Patent 10028923 Biguanide compositions and methods of treating metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
